ROLE OF HUMAN ANGIOPOIETIN-LIKE PROTEIN 3 (ANGPTL3) GLYCOSYLATION IN THE PROTEIN SECRETION AND STABILITY

被引：0
|
作者：
Burza, M. A. [1 ,2 ]
Pirazzi, C. [3 ,4 ]
Maglio, C. [3 ,4 ]
Molinaro, A. [2 ]
Corradini, S. Ginanni [2 ]
Romeo, S. [1 ,3 ,4 ]
机构：
[1] Univ Cambridge, Cambridge, England
[2] Univ Roma La Sapienza, Div Gastroenterol, Dept Clin Med, Rome, Italy
[3] Gothenburg Univ, Sahlgrens Hosp, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden
[4] Gothenburg Univ, Sahlgrens Hosp, Ctr Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2011年 / 12卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(11)70015-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
14
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [1] Atypical angiopoietin-like protein that regulates ANGPTL3
    Quagliarini, Fabiana
    Wang, Yan
    Kozlitina, Julia
    Grishin, Nick V.
    Hyde, Rhonda
    Boerwinkle, Eric
    Valenzuela, David M.
    Murphy, Andrew J.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (48) : 19751 - 19756
  • [2] Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis
    Lu, Xinjie
    [J]. CURRENT MEDICINAL CHEMISTRY, 2020, 27 (31) : 5159 - 5174
  • [3] Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
    Tarugi, Patrizia
    Bertolini, Stefano
    Calandra, Sebastiano
    [J]. JOURNAL OF BIOMEDICAL RESEARCH, 2019, 33 (02): : 73 - 81
  • [4] Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
    Chen, Pei-Yi
    Gao, Wan-Yun
    Liou, Je-Wen
    Lin, Ching-Yen
    Wu, Ming-Jiuan
    Yen, Jui-Hung
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [5] Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
    Patrizia Tarugi
    Stefano Bertolini
    Sebastiano Calandra
    [J]. The Journal of Biomedical Research, 2019, 33 (02) : 73 - 81
  • [6] Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
    Kosmas, Constantine E.
    Bousvarou, Maria
    Sourlas, Andreas
    Papakonstantinou, Evangelia J.
    Genao, Edilberto Pella
    Uceta, Rogers Echavarria
    Guzman, Eliscer
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2022, 14 : 49 - 59
  • [7] Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia
    Wiggins, Barbara S.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (05) : e631 - e640
  • [8] Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia
    Shoji, Tetsuo
    Hatsuda, Sawako
    Tsuchikura, Shoko
    Kimoto, Eiji
    Kakiya, Ryusuke
    Tahara, Hideki
    Koyama, Hidenori
    Emoto, Masanori
    Tabata, Tsutomu
    Nishizawa, Yoshiki
    [J]. ATHEROSCLEROSIS, 2009, 207 (02) : 579 - 584
  • [9] Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome
    Vatannejad, Akram
    Salimi, Fouzieh
    Moradi, Nariman
    Fouani, Fatima Zahraa
    Zandieh, Zahra
    Ansaripour, Soheila
    Sadeghi, Asie
    Fadaei, Reza
    [J]. LIFE SCIENCES, 2020, 263
  • [10] Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3) -: ANGPTL3 is cleaved and activated in vivo
    Ono, M
    Shimizugawa, T
    Shimamura, M
    Yoshida, K
    Noji-Sakikawa, C
    Ando, Y
    Koishi, R
    Furukawa, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) : 41804 - 41809
12345